Molecular diagnosis in pediatric acute leukemias

Clinics in Laboratory Medicine

Volumn 20, Issue 1, 2000, Pages 139-182

  Bartolo, C ^a   Viswanatha, D S ^a  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LYMPHOCYTE ANTIGEN RECEPTOR;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; CELL LINEAGE; CHILDHOOD LEUKEMIA; CHROMOSOME 11Q; CHROMOSOME 12P; CHROMOSOME 19P; CHROMOSOME 1Q; CHROMOSOME 21Q; CHROMOSOME 22Q; CHROMOSOME 8Q; CHROMOSOME 9Q; CHROMOSOME INVERSION; CHROMOSOME TRANSLOCATION; CLINICAL EXAMINATION; FLUORESCENCE IN SITU HYBRIDIZATION; GENE FUSION; GENE REARRANGEMENT; HUMAN; ONCOGENE C MYC; PRIORITY JOURNAL; PROTO ONCOGENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; TUMOR SUPPRESSOR GENE;

EID: 0033998134     PISSN: 02722712     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0272-2712(18)30081-7     Document Type: Review

References (352)

1. 2 into cytoskeletal filaments and aggregates Mol Cell Biol 18 1998 7432
2. Akasaka T. Yonetani N. Akasaka H. Detection of t(8;14)(q24;q32) by polymerase chain reaction for long DNA targets: A report of two patients with B-cell non-Hodgkin’s lymphoma Int J Hematol 67 1998 75
3. Alcalay M. Zangrilli D. Pandolfi P.P. Translocation breakpoint of acute promyelocytic leukemia lies within the retinoic acid receptor α locus Proc Natl Acad Sci U S A 88 1991 1977
4. Amati B. Brooks M.W. Levy N. Oncogenic activity of the c-myc protein requires dimerization with Max Cell 72 1993 233
5. Apian P.D. Lombardi D.P. Ginsberg A.M. Disruption of the human SCL locus by “illegitimate” V-(D)-J recombinase activity Science 250 1990 1426
6. Apian P.D. Lombardi D.P. Reaman G.H. Involvement of the putative hematopoietic transcription factor SCL in T-cell acute lymphoblastic leukemia Blood 79 1992 1327
7. Ayer D.E. Kretzner L. Eisenman R.N. Mad: A heterodimeric partner for Max that antagonizes myc transcriptional activity Cell 72 1993 211
8. Ayer D.E. Lawrence Q.A. Eisenman R.N. Mad-Max transcriptional repression is mediated by ternary complex formation with mammalian homologs of yeast repressor sin3 Cell 80 1995 767
9. Bain G. Robanus Maandag E.C. Izon D.J. E2A proteins are required for proper B-cell development and initiation of immunoglobulin gene rearrangements Cell 79 1994 885
10. Barnard D.R. Kalousek D.K. Wiersma S.R. Morphologic, immunologic and cytogenetic classification of acute myeloid leukemia and myelodysplastic syndrome in childhood: A report from the Childrens Cancer Group Leukemia 10 1996 5
11. Bash R.O. Crist W.M. Shuster J.J. Clinical features and outcome of T-cell acute lymphoblastic leukemia in childhood with respect to alterations at the TALI locus: A Pediatric Oncology Group study Blood 81 1993 2110
12. Batova A. Diccianni M.B. Yu J.C. Frequent and selective methylation of p15 and deletion of both p15 and pi6 in T-cell acute lymphoblastic leukemia Cancer Res 57 1997 832
13. Begley C.G. Apian P.D. Denning S.M. The gene SCL is expressed during early hematopoiesis and encodes a differentiation-related DNA-binding motif Proc Natl Acad Sci U S A 86 1989 10128
14. Behm F.G. Raimondi S.C. Frestedt J.L. Rearrangement of the MLL gene confers a poor prognosis in childhood acute lymphoblastic leukemia, regardless of presenting age Blood 87 1996 2870
15. Behm F.G. Smith F.O. Raimondi S.C. Human homologue of the rate chondroitin sulfate proteoglycan, NG2, detected by monoclonal antibody 7.1, identifies childhood acute lymphoblastic leukemias with t(4;11)(q21;q23) or t(11;19)(q23;p13) and MLL gene rearrangements Blood 87 1996 1134
16. Bennett J.M. Catovsky D. Daniel M.T. A variant form of hypergranular promyelocytic leukemia (M3) Ann Intern Med 92 1980 261
17. Bentz M. Cabot G. Moos M. Detection of chimeric bcr-abl genes on bone marrow samples and blood smears in chronic myeloid leukemia and acute lymphoblastic leukemia by in situ hybridization Blood 83 1994 1922
18. Beran M. Cao X. Estrov Z. Selective inhibition of cell proliferation and BCR-ABL phosphorylation in acute lymphoblastic leukemia cells expressing Mr 190,000 BCR-ABL protein by a tyrosine kinase inhibitor (CGP-57148) Clin Cancer Res 4 1998 1661
19. Beyermann B. Agthe A.G. Adams H-P. Clinical features and outcome of children with first marrow relapse of acute lymphoblastic leukemia expressing BCR-ABL fusion transcripts Blood 87 1996 1532
20. Biernaux C. Loos M. Sels A. Detection of major bcr-abl gene expression at a very low level in blood cells of some healthy individuals Blood 86 1995 3118
21. Biondi A. Rambaldi A. Pandolfi P.P. Molecular monitoring of myl/ retinoic acid receptor-a fusion gene in acute promyelocytic leukemia by polymerase chain reaction Blood 80 1992 492
22. Biondi A. Rambaldi A. Rossi V. Detection of ALL-1 /AF4 fusion transcript by reverse transcription/polymerase chain reaction for diagnosis and monitoring of acute leukemias with the t(4;11) translocation Blood 82 1993 2943
23. Biondi A. Roveli A. Cantu-Rajnoldi A. Acute promyelocytic leukemia in children: Experience of the Italian Pediatric Hematology and Oncology Group (AIEOP) Leukemia 8 1994 1264
24. Blackwood E.M. Eisenman R.N. Max: A helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with myc Science 251 1991 1211
25. Boehm T. Baer R. Lavenir I. The mechanism of chromosomal translocation t(11;14) involving the T-cell receptor C delta locus on human chromosome 14q11 and a transcribed region of chromosome 11p15 EMBO J 7 1988 385
26. Boehm T. Foroni L. Kaneko Y. The rhombotin family of cysteine-rich LIM-domain oncogenes: Distinct members are involved in T-cell translocations to human chromosomes 11p15 and 11p13 Proc Natl Acad Sci U S A 88 1991 4367
27. Borkhardt A. Cazzaniga G. Viehmann S. Incidence and clinical relevance of TEL/AML1 fusion genes in children with acute lymphoblastic leukemia enrolled in German and Italian multicenter therapy trials Blood 90 1997 571
28. Borkhardt A. Harbott J. Lampert F. Biology and clinical significance of the TEL/AML1 rearrangement Curr Opin Pediatr 11 1999 33
29. Borowitz M.J. Hunger S.P. Carroll A.J. Predictability of the t(1;19)(q23;p13) from surface antigen phenotype. Implications for screening cases of childhood ALL for molecular analysis. A Pediatric Oncology Group Study Blood 82 1993 1086
30. Borrow J. Goddard A.D. Sheer D. Solomon E. Molecular analysis of acute promyelocytic leukemia breakpoint cluster region on chromosome 17 Science 249 1990 1577
31. Bose S. Deininger M. Gora-Tybor J. The presence of typical and atypical BCR-ABE fusion genes in leukocytes of normal individuals: Biologic significance and implications for the assessment of minimal residual disease Blood 92 1998 3362
32. Breit T.M. Beishuizen A. Ludwig W.D. tal-1 deletions in T cell acute lymphoblastic leukemia as PCR target for detection of minimal residual disease Leukemia 7 1993 2004
33. Brisco M.J. Condon J. Hughes E. Outcome prediction in childhood acute lymphoblastic leukaemia by molecular quantification of residual disease at the end of induction Lancet 343 1994 196
34. Brown L. Cheng J-T. Chen Q. Site-specific recombination of the tal-1 gene is a common occurrence in human T cell leukemia EMBO J 9 1990 3343
35. Buijs A. Sherr S. van Baal S. Translocation (12;21)(p13;q11) in myeloproliferative disorders results in fusion of the ETS-like TEE gene on 12p13 to the MN1 gene on 22q11 Oncogene 10 1995 1511
36. Burnett R.C. David J.C. Harden A.M. The lek gene is involved in the t(1;7)(P34;Q34) in the T-cell acute lymphoblastic leukemia derived cell line, hsb- 2 Gene Chromosom Cancer 3 1991 461
37. Carroll A.J. Crist W.M. Link M.P. The t(1;14)(p34;q11) is nonrandom and restricted to T-cell acute lymphoblastic leukemia: A Pediatric Oncology Group study Blood 76 1990 1220
38. Carroll M. Ohno-Jones S. Tamura S. CGP 57148, a tyrosine kinase inhibitor, inhibits the growth of cells expressing BCR-ABL , TEL-ABL , and TEE-PDGFR fusion proteins Blood 90 1997 4947
39. Castaigne S. Balitrand N. de The H. A PML/retinoic acid receptor a fusion transcript is constantly detected by RNA-based polymerase chain reaction in acute promyelocytic leukemia Blood 79 1992 3110
40. p190 fusion gene made by homologous recombination causes B-cell acute lymphoblastic leukemias in chimeric mice with independence of the endogenous her product Blood 90 1997 2168
41. Castillo L.H. Wijmenga C. Wang Q. Failure of embryonic hematopoiesis and lethal hemorrhages in mouse embryos heterozygous for a knocked-in leukemia gene CBFB-MYH11 Cell 87 1996 687
42. Cavé H. Guidal C. Rohrlich P. Prospective monitoring and quantitation of residual blasts in childhood acute lymphoblastic leukemia by polymerase chain reaction study of δ and γ T-cell receptor genes Blood 83 1994 1892
43. Cavé H. van der Werf ten Bosch J. Suciu S. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia N Engl J Med 339 1998 591
44. Cayuela J.M. Baruchel A. Orange C. TEL-AML1 fusion RNA as a new target to detect minimal residual disease in pediatric B-cell precursor acute lymphoblastic leukemia Blood 88 1996 302
45. Cayuela J.M. Madani A. Sanhes L. Multiple tumor-suppressor gene 1 inactivation is the most frequent genetic alteration in T-cell acute lymphoblastic leukemia Blood 87 1996 2180
46. Chambon P. A decade of molecular biology of retinoid receptors FASEB J 10 1996 940
47. INK4 Mol Cell Biol 15 1995 2682
48. Chang C-P. Shen W-F. Rozenfeld S. Pbx proteins display hexapeptide-dependent cooperative DNA binding with a subset of Hox proteins Genes Dev 9 1995 663
49. Chen C-S. Sorensen P.H.B. Domer P.H. Molecular rearrangements on chromosome 11q23 predominate in infant acute lymphoblastic leukemia and are associated with specific biologic variables and poor outcome Blood 81 1993 2386
50. Chen Q. Cheng J.T. Tasi L.H. The tal gene undergoes chromosome translocation in T cell leukemia and potentially encodes a helix-loop-helix protein EMBO 9 1990 415
51. Chen S-J. Chen Z. Chen A. Occurrence of distinct PML-RARα fusion gene isoforms in patients with acute promyelocytic leukemia detected by reverse transcriptase/polymerase chain reaction Oncogene 7 1992 1223
52. Chen Z. Brand N. Chen A. Fusion between a novel Kruppel- like zinc finger gene and the retinois acid receptor-a locus due to a variant t(11;17) translocation associated with acute promyelocytic leukemia EMBO J 12 1993 1161
53. Chen Z. Guidez F. Rousselot P. PLZF-RARα fusion proteins generated from the variant t(11;17)(q23;21) translocation in acute promyelocytic leukemia inhibit ligand-dependent transactivation of wild type retinoic acid receptors Proc Natl Acad Sci USA 91 1994 1178
54. Chen Z. Morgan R. Berger C.S. Identification of masked and variant Ph (complex type) translocations in CML and classic Ph in AML and ALL by fluorescence in situ hybridization with the use of bcr/abl cosmid probes Cancer Genet Cytogenet 70 1993 103
55. Cimino G. Lo Coco F. Biondi A. ALL-1 gene at chromosome 11q23 is consistently altered in acute leukemia of early infancy Blood 82 1993 544
56. Cimino G. Rapanotti M.C. Biondi A. Infant acute leukemias show the same biased distribution of ALL1 gene breaks as topoisomerase II related secondary acute leukemias Cancer Res 57 1997 2879
57. Cimino G. Rapanotti M.C. Rivolta A. Prognostic relevance of ALL-1 gene rearrangement in infant acute leukemias Leukemia 9 1995 391
58. Clark S.S. McLaughlin J. Crist W.M. Unique forms of the abl tyrosine kinase distinguish Ph-positive CML from Ph-positive ALL Science 235 1987 85
59. Claxton D.F. Liu P.P. Hsu H.B. Detection of fusion transcripts generated by the inversion 16 chromosome in acute myelogenous leukemia Blood 83 1994 1750
60. Collins S.J. Acute promyelocytic leukemia: Relieving repression induces remission Blood 91 1998 2631
61. Corral J. Lavenir I. Impey H. An M11-AF9 fusion gene made by homologous recombination causes acute leukemia in chimeric mice: A method to create fusion oncogenes Cell 85 1996 853
62. Cossman J. Uppenkamp M. Sudeen J. Molecular genetics and the diagnosis of lymphoma Arch Pathol Lab Med 112 1988 117
63. Costello R. Sainty D. Lecine P. Detection of CBFβ-MYHll fusion transcripts in acute myeloid leukemia: Heterogeneity of cytological and molecular characteristics Leukemia 11 1997 644
64. Crist W. Carroll A. Shuster J. Philadelphia chromosome positive childhood acute lymphoblastic leukemia: Clinical and cytogenetic characteristics and treatment outcome. A Pediatric Oncology Group study Blood 76 1990 489
65. Crist W.M. Carroll A.J. Shuster J.J. Poor prognosis of children with pre-B acute lymphoblastic leukemia is associated with the t(1;19)(q23;p13): A Pediatric Oncology Group study Blood 76 1990 117
66. Crist W. Pullen J. Boyett J. Clinical and biologic features predict a poor prognosis in acute lymphoid leukemias in infants: A Pediatric Oncology Group study Blood 67 1986 135
67. Crist W.M. Shuster J.J. Falletta J. Clinical features and outcome in childhood T-cell leukemia—lymphoma according to stage of thymocyte differentiation: A Pediatric Oncology Group study Blood 72 1988 1891
68. Croce C.M. Nowell P.C. Molecular basis of human B cell neoplasia Blood 65 1985 1
69. Davey F.R. Davis R.B. MacCallum J.M. Morphologic and cytochemical characteristics of acute promyelocytic leukemia Am J Hematol 30 1989 221
70. Dedera D.A. Waller E.K. LeBrun D.P. Chimeric homeobox gene E2A-PBX1 induces proliferation, apoptosis and malignant lymphomas in transgenic mice Cell 74 1993 833
71. Degos L. Dombret H. Chomienne C. All -trans retinoic acid as a differentiating agent in the treatment of acute promyelocytic leukemia Blood 85 1995 2643
72. Deininger M.W. Goldman J.M. Lydon N. Melo J.V. The tyrosine kinase inhibitor CGP57148B selectively inhibits the growth of BCR-ABL-positive cells Blood 90 1997 3691
73. De Risi J. Penland L. Brown P.O. Use of a cDNA microarray to analyse gene expression patterns in human cancer Nat Genet 14 1996 457
74. De The H. Chomienne C. Lanotte M. The t(15;17) translocation of acute promyelocytic leukemia fuses the retinoic acid receptor a gene to a novel transcribed locus Nature 347 1990 558
75. Devaraj P.E. Foroni L. Janossy G. Expression of the E2A-PBX1 fusion transcripts in t(1;19)(q23;p13) and der(19)t(1;19) at diagnosis and in remission of acute lymphoblastic leukemia with different B lineage immunophenotypes Leukemia 9 1995 821
76. Devaraj P.E. Foroni L. Sekhar M. E2A/HLF fusion cDNAs and the use of RT-PCR for the detection of minimal residual disease in t(17;19)(q22;p13) acute lymphoblastic leukemia Leukemia 8 1994 1131
77. Dewald G.W. Schad C.R. Christensen E.R. The application of fluorescent in situ hybridization to detect M bcr/abl fusion in variant Ph chromosome in CML and ALL Cancer Genet Cytogenet 71 1993 7
78. Diverio D. Pandolfi P.P. Biondi A. Absence of reverse transcription polymerase chain reaction detectable residual disease in patients with acute promyelocytic leukemia in long-term remission Blood 12 1993 3556
79. Diverio D. Pandolfi P.P. Rossi V. Monitoring of treatment outcome in acute promyelocytic leukemia by RT-PCR Leukemia 8 1994 S63
80. Djabali M. Selleri L. Parry P. A trithorax-like gene is interrupted by chromosome 11q23 translocations in acute leukaemias Nat Genet 2 1992 113
81. Dolken G. Illerhaus G. Hirt C. Mertelsmann R. BCL-2/JH rearrangements in circulating B cells of healthy blood donors and patients with non-malignant diseases J Clin Oncol 14 1996 1333
82. Douer D. Preston-Martin S. Chang E. High frequency of acute promyelocytic leukemia among Latinos with acute myeloid leukemia Blood 87 1996 308
83. Dowell B.L. Borowitz M.J. Boyett J.M. Immunologic and clinicopathologic features of common acute lymphoblastic leukemia antigen-positive childhood T-cell leukemia. A Pediatric Oncology Group study Cancer 59 1987 2020
84. Downing J.R. Head D.R. Cucio-Brint A.M. An AML1/ETO fusion transcript is consistently detected by RNA-based polymerase chain reaction in acute myelogenous leukemia containing the (8;21)(q22;q22) translocation Blood 81 1993 2860
85. Downing J.R. Head D.R. Raimondi S.C. The der(11)-encoded MLL/AF-4 fusion transcript is consistently detected in t(4;11)(q21;q23)-containing acute lymphoblastic leukemia Blood 83 1994 330
86. Drexler H.G. Review of alterations of the cyclin-dependent kinase inhibitor INK4 family genes p15, p16, p18 and p19 in human leukemia-lymphoma cells Leukemia 12 1998 845
87. Dube I.D. Kamel Reid S. Yuan C.C. A novel human homeobox gene lies at the chromosome 10 breakpoint in lymphoid neoplasias with chromosomal translocation t(10;14) Blood 78 1991 2996
88. Dyck J.A. Maul G.G. Miller W.H. Jr A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein Cell 76 1994 333
89. Elwood N.J. Cook W.D. Metcalf D. Begley C.G. SCL, the gene implicated in human T-cell leukaemia, is oncogenic in a murine T-lymphocyte cell line Oncogene 8 1993 3093
90. Erickson P. Gao J. Chang K-S. Identification of breakpoints in t(8;21) AML and isolation of a fusion transcript with similarity to Drosophila segmentation gene runt Blood 80 1992 1825
91. Erickson P.F. Robinson M. Owens G. Drabkin H.A. The ETO portion of acute myeloid leukemia t(8;21) fusion transcript encodes a highly evolutionary conserved putative transcription factor Cancer Res 54 1994 1782
92. Evans P.A.S. Short M.A. Owen R.G. Residual disease detection using fluorescent polymerase chain reaction at 20 weeks of therapy predicts clinical outcome in childhood acute lymphoblastic leukemia J Clin Oncol 16 1998 3616
93. Felix C.A. Winick N.J. Negrini M. Common region of ALL-1 gene disrupted in epipodophyllotoxin-related secondary acute myeloid leukemia Cancer Res 53 1993 2954
94. Fenrick R. Hiebert S.W. Role of histone deacetylases in acute leukemia J Cell Biochem 30-31 1998 194
95. Finger L.R. Kagan J. Christopher G. Involvement of the TCL5 gene on human chromosome 1 in T-cell leukemia and melanoma Proc Natl Acad Sci USA 86 1989 5039
96. Finver S.N. Nishikura K. Finger L.R. Sequence analysis of the MYC oncogene involved in the t(8;14)(q24;q11) chromosome translocation in a human leukemia T-cell line indicates that putative regulatory regions are not altered Proc Natl Acad Sci USA 85 1988 3052
97. Fizzotti M. Cimino G. Pisegna S. Detection of homozygous deletions of the cyclin-dependent kinase 4 inhibitor (p16) gene in acute lymphoblastic leukemia and association with adverse prognostic features Blood 85 1995 2685
98. Flegel W.A. Singson A.W. Margolis J.S. Dpbx, a new homeobox gene closely related to the human proto-oncogene Pbxl: Molecular structure and developmental expression Mech Dev 41 1993 155
99. Fletcher J.A. Lynch E.A. Kimball V.M. Translocation (9;22) is associated with extremely poor prognosis in intensively treated children with acute lymphoblastic leukemia Blood 77 1991 435
100. Foroni L. Coyle L.A. Papaioannou M. Molecular detection of minimal residual disease in adult and childhood acute lymphoblastic leukaemia reveals differences in treatment response Leukemia 11 1997 1732
101. Foroni L. Harrison C. Hoffbrand A.V. Potter M.N. Investigation of minimal residual disease in childhood and adult acute lymphoblastic leukemia by molecular analysis Br J Haematol 105 1999 7
102. Frank R. Zhang H. Uchida H. The AML1/ETO fusion protein blocks transactivation of the GM-CSF promoter by AML1B Oncogene 11 1995 2667
103. Gale K.B. Ford A.M. Repp R. Backtracking leukemia to birth: Identification of clonotypic gene fusion sequences in neonatal blood spots Proc Natl Acad Sci U S A 94 1997 13950
104. Gallagher R.E. Li Y-P. Rao S. Characterization of acute promyelocytic leukemia cases with PML-RARα break/fusion sites in PML exon 6: Identification of a subgroup with decreased in vitro responsiveness to all -trans retinoic acid Blood 86 1995 1540
105. Gallagher R.E. Willman C.L. Slack J.L. Association of PML-RARα fusion mRNA type pretreatment hematologic characteristics but not treatment outcome in acute promyelocytic leukemia: An Intergroup molecular study Blood 90 1997 1656
106. Garand R. Vannier J.P. Bene M.C. Comparison of outcome, clinical, laboratory, and immunological features in 164 children and adults with T-ALL. The Groupe D’Etude Immunologique Des Leucemies Leukemia 4 1990 739
107. Garcia I.S. Kaneko Y. Gonzalez Sarmiento R. A study of chromosome 11p13 translocations involving TCR beta and TCR delta in human T cell leukaemia Oncogene 6 1991 577
108. ARF encoding exons in T-cell acute lymphoblastic leukemia Blood 91 1998 1016
109. Gaynon P.S. Crotty M.L. Sather H.N. Expression of BCR-ABL, E2A-PBX1 and MLL-AF4 fusion transcripts in newly diagnosed children with acute lymphoblastic leukemia: A Children’s Cancer Group initiative Leuk Lymphoma 26 1997 57
110. Gehly G.B. Bryant E.M. Lee A.M. Chimeric BCR-ABL messenger RNA as a marker for minimal residual disease in patients transplanted for Philadelphia chromosomepositive acute lymphoblastic leukemia Blood 78 1991 458
111. Golomb H.M. Rowley J.D. Vardiman J.W. “Microgranular” acute promyelocytic leukemia: A distinct clinical, ultrastructural and cytogenetic entity Blood 55 1980 253
112. Golub T.R. Barker G.F. Bohlander S.K. Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia Proc Natl Acad Sci USA 92 1995 4917
113. Golub T.R. Barker G.F. Lovett M. Gilliland D.G. Fusion of PDGF receptor β to a novel ets-like gene, tel, in chronic monomyelocytic leukemia with t(5;12) chromosomal translocation Cell 77 1994 307
114. Gottschalk L.R. Leiden J.M. Identification and functional characterization of the human T-cell receptor β gene transcriptional enhancer: Common nuclear proteins interact with the transcriptional regulatory elements of the T-cell receptor α and β genes Mol Cell Biol 10 1990 5486
115. Goulden N.J. Knechtli C.J. Garland R.J. Minimal residual disease analysis for the prediction of relapse in children with standard-risk acute lymphoblastic leukaemia Br J Haematol 100 1998 235
116. Griffin T.C. Bowman W.P. Winick N.J. Buchanan G.R. Treatment of advanced stage diffuse small non-cleaved-cell lymphoma in childhood: Further experience with total therapy B Med Pediatr Oncol 23 1994 393
117. Grignani F. De Matteis S. Nervi C. Fusion proteins of the retinoic acid receptor-α recruit histone deacetylase in promyelocytic leukaemia Nature 391 1998 815
118. Grignani F. Fagioloi M. Alcalay M. Acute promyelocytic leukemia: From genetics to treatment Blood 83 1994 10
119. Gruhn B. Hongeng S. Yi H. Minimal residual disease after intensive induction therapy in childhood acute lymphoblastic leukemia predicts outcome Leukemia 12 1998 675
120. Grunstein M. Histone acetylation in chromatin structure and transcription Nature 389 1997 349
121. Gu Y. Alder H. Nakamura T. Sequence analysis of the breakpoint cluster region in the ALL-1 gene involved in acute leukemia Cancer Res 54 1994 2327
122. Gu Y. Cimino G. Alder H. The (4;11)(q21;q23) chromosome translocations in acute leukemias involve the VDJ recombinase Proc Natl Acad Sci U S A 89 1992 10464
123. Gu Y. Nakamura T. Alder H. The t(4;11) chromosome translocation of human acute leukemias fuses the ALL-1 gene, related to Drosophila trithorax to the AF-4 gene Cell 171 1992 701
124. Guidal Giroux C. Gerard B. Cave H. Deletion mapping indicates that MTS1 is the target of frequent deletions at chromosome 9p21 in paediatric acute lymphoblastic leukaemias Br J Haematol 92 1996 410
125. Guidez F. Ivins S. Zhu J. Reduced retinoic acid-sensitivities of nuclear corepressor binding to PML- and PLZF-RARα underlie molecular pathogenesis and treatment of acute promyelocytic leukemia Blood 91 1998 2634
126. Harbott J. Viehmann S. Borkhardt A. Incidence of TEL/AML1 fusion gene analyzed consecutively in childhood with acute lymphoblastic leukemia in relapse Blood 90 1997 4933
127. Harris C.C. p53: At the crossroads of molecular carcinogenesis and risk assessment Science 262 1993 1980
128. Hatano M. Roberts C.W. Minden M. Deregulation of a homeobox gene, HOX11, by the t(10;14) in T cell leukemia Science 253 1991 79
129. INK4b) display frequent homozygous deletions in primary cells from T-but not from B-cell lineage acute lymphoblastic leukemias Blood 84 1994 4038
130. Hebert J. Cayuela J-M. Daniel M-T. Detection of minimal residual disease in acute myelomonocytic leukemia with abnormal eosinophils by nested polymerase chain reaction with allele specific amplification Blood 84 1994 2291
131. Heid C. Stevens J. Kivak K.J. Williams P.M. Real time quantitative PCR Genome Res 6 1996 986
132. Henthorn P. Kiledjian M. Kadesch T. Two distinct transcription factors that bind the immunoglobulin enhancer μE5/κE2 motif Science 247 1990 467
133. INK4B characterize major types of hematological malignancies Cancer Res 57 1997 837
134. INK4B Cancer Res 56 1996 722
135. Hermans A. Heisterkamp N. von Lindern M. Unique fusion of her and c- abl genes in Philadelphia chromosome positive acute lymphoblastic leukemia Cell 51 1987 33
136. INK4a gene inactivation in childhood acute lymphoblastic leukemia J Clin Oncol 14 1996 1512
137. Hilden J.M. Frestedt J.L. Moore R.O. Molecular analysis of infant acute lymphoblastic leukemia: MLL gene rearrangement and reverse transcriptase-polymerase chain reaction for t(4;11)(q21;q23) Blood 86 1995 3876
138. Hirai H. Roussel M.F. Kato J.Y. Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6 Mol Cell Biol 15 1995 2672
139. bcr/abl: A novel transgenic model for human PlF-positive leukemias Blood 91 1998 2067
140. Hsiang Y.H. Spencer D. Wang S. The role of viral “core” motif-related sequences in regulating T-cell receptor γ and δ gene expression J Immunol 150 1993 3905
141. Hudson M.M. Raimondi S.C. Behm F.G. Childhood leukemia with t(11;19)(q23;p13) Leukemia 5 1991 1064
142. Hunger S.P. Chromosomal translocations involving the E2A gene in acute lymphoblastic leukemia: Clinical features and molecular pathogenesis Blood 87 1996 1211
143. Hunger S.P. Cleary M.L. What significance should we attribute to the detection of MLL fusion transcripts? Blood 92 1998 709
144. Hunger S.P. Galili N. Carroll A.J. The t(1;19)(q23;p13) results in consistent fusion of E2A and PBX1 coding sequences in acute lymphoblastic leukemias Blood 77 1991 687
145. Hunger S.P. Ohyashiki K. Toyama K. HLF, a novel hepatic bZIP protein, shows altered DNA-binding properties following fusion to E2A in t(17;19) acute lymphoblastic leukemia Genes Dev 6 1992 1608
146. Hunger S.P. Tkachuk D.C. Amylon M.D. HRX involvement in de novo and secondary leukemias with diverse chromosome 11q23 abnormalities Blood 81 1993 3197
147. Ikeda K. Sasaki K. Tasaka T. Reverse transcription-polymerase chain reaction for PML/RARa fusion transcripts in acute promyelocytic leukemia and its application to minimal residual leukemia detection Leukemia 7 1993 544
148. Inaba T. Roberts W.M. Shapiro L.H. Fusion of the leucine zipper gene HLF to the E2A gene in human acute B-lineage leukemia Science 257 1992 531
149. Issa J.P.J. Baylin S.B. Herman J.G. DNA methylation changes in hematologic malignancies: Biologic and clinical implications Leukemia 11 suppl 1 1997 S7
150. Ito Y. Wasserman R. Galili N. Molecular residual disease status at the end of chemotherapy fails to predict subsequent relapse in children with B-lineage acute lymphoblastic leukemia J Clin Oncol 11 1993 546
151. Izraeli S. Janssen W.S.G. Haas O.A. Detection and clinical relevance of genetic abnormalities in pediatric acute lymphoblastic leukemia: A comparison between cytogenetic and polymerase chain reaction analyses Leukemia 7 1993 671
152. Izraeli S. Kovar H. Gadner H. Unexpected heterogeneity in E2A/PBX1 fusion messenger RNA detected by the polymerase chain reaction in pediatric patients with acute lymphoblastic leukemia Blood 80 1992 1413
153. Jacquy C. Delepaut B. Van Daele S. A prospective study of minimal residual disease in childhood B-lineage acute lymphoblastic leukaemia: MRD level at the end of induction is a strong predictive factor of relapse Br J Haematol 98 1997 140
154. Janssen J.W.G. Ludwig W-D. Borkhardt A. Pre-pre-B acute lymphoblastic leukemia: High frequency of alternatively spliced ALL1-AF4 transcripts and absence of minimal residual disease during complete remission Blood 84 1994 3835
155. Jonsson O.G. Kitchens R.L. Baer R.J. Rearrangements of the tal-1 locus as clonal markers for T cell acute lymphoblastic leukemia J Clin Invest 87 1991 2029
156. Jurlander J. Caligiuri M.A. Ruutu T. Persistence of the AML1/ETO fusion transcript in patients treated with allogeneic bone marrow transplantation for t(8;21) leukemia Blood 88 1996 2183
157. Kagan J. Finger L.R. Letofsky J. Clustering of breakpoints on chromosome 10 in acute T-cell leukemias with the t(10;14) chromosome translocation Proc Natl Acad Sci U S A 86 1989 4161
158. Kagoshima H. Shigesada K. Satake M. The Runt domain identifies a new family of heterodimeric transcriptional activators Trends Genet 9 1993 338
159. Kakizuka A. Miller W.H. Jr Umesono K. Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RARa with a novel putative transcription factor PML Cell 66 1991 663
160. Kamps M.P. Baltimore D. E2A-Pbxl, the t(1;19) translocation protein of human pre-B-cell acute lymphocytic leukemia, causes acute myeloid leukemia in mice Mol Cell Biol 13 1993 351
161. Kamps M.P. Look A.T. Baltimore D. The human t(1;19) translocation in pre-B ALL produces multiple nuclear E2A-Pbxl fusion proteins with differing transforming potentials Genes Dev 5 1991 358
162. Kamps M.P. Murre C. Sun X.H. A new homeobox gene contributes the DNA binding domain of the t(1;19) translocation protein in pre-B ALL Cell 60 1990 547
163. Kane J.R. Head D.R. Balazs L. Molecular analysis of the PML/RARa chimeric gene in pediatric acute promyelocytic leukemia Leukemia 10 1996 1296
164. Kees U. Burton P.R. Lu C. Baker D.L. Homozygous deletion of the p16 /MTS1 gene in pediatric acute lymphoblastic leukemia is associated with unfavorable clinical outcome Blood 89 1997 4161
165. Kennedy M.A. Gonzalez Sarmiento R. Kees U.R. HOX11, a homeobox-containing T-cell oncogene on human chromosome 10q24 Proc Natl Acad Sci U S A 88 1991 8900
166. Kim-Rouille M-H. MacGregor A. Wiedeman L.M. MLL-AF4 gene fusions in normal newborns Blood 93 1999 1007
167. Konopka J.B. Watanabe S.M. Witte O.N. An alteration of the human c -abl protein in K-562 leukemia cells unmasks associated tyrosine kinase activity Cell 37 1984 1035
168. Kozu T. Miyoshi H. Shimizu K. Junctions of the AML1/MTG8 (ETO) fusion are constant in t(8;21) acute myeloid leukemia detected by reverse transcription polymerase chain reaction Blood 82 1993 1270
169. Kurzrock R. Gutterman J.U. Talpaz M. The molecular genetics of Philadelphia chromosome-positive leukemias N Engl J Med 319 1988 990
170. Kusec R. Laczika K. Knobl P. AML1/ETO fusion mRNA can be detected in remission blood samples of all patients with t(8;21) acute myeloid leukemia after chemotherapy or autologous bone marrow transplantation Leukemia 8 1994 735
171. Lampert F. Harbott J. Ritterbach J. Karyotypes in acute childhood leukemias may lose prognostic significance with more intensive and specific chemotherapy Cancer Genet Cytogenet 54 1991 277
172. Landman-Parker J. Aubin J. Delabesse E. Simplified strategies for minimal residual disease detection in B-cell precursor acute lymphoblastic leukaemia Br J Haematol 95 1996 281
173. Lanza C. Gottardi E. Gaidana G. Persistence of E2A/PBX1 transcripts in t(1;19) childhood acute lymphoblastic leukemia: Correlation with chemotherapy intensity and clinical outcome Leuk Res 20 1996 441
174. Lassar A.B. Murre C. Davis R.L. Functional activity of myogenic HLH proteins requires hetero-oligomerization with E12/E47- like proteins in vivo Cell 66 1991 305
175. Leblanc T. Berger R. Molecular cytogenetics of childhood acute myelogenous leukemias Eur J Haematol 59 1997 1
176. Lemons R.S. Eilender D. Waldmann R.A. Cloning and characterization of the t(15;17) translocation breakpoint region in acute promyelocytic leukemia Genes Chromosomes Cancer 2 1990 79
177. Lemons R.S. Keller S. Gietzen D. Acute promyelocytic leukemia J Pediatr Hematol Oncol 17 1995 198
178. Licht J.D. Chomienne C. Goy A. Clinical and molecular characterization of a rare syndrome of acute promyelocytic leukemia associated with translocation (11;17) Blood 85 1995 1083
179. Limpens J. Stad R. Vos C. Lymphoma-associated translocation t(14;18) in blood B cells of normal individuals Blood 85 1995 2528
180. Lin R.J. Nagy L. Inoue S. Role of the histone deacetylase complex in acute promyelocytic leukemia Nature 391 1998 811
181. Liu P. Tarle S.A. Hajra A. Fusion between transcription factor CBFβ/PEBP2β and a myosin heavy chain in acute myeloid leukemia Science 261 1993 1041
182. Liu P.P. Hajra A. Wijmenga C. Collins F.S. Molecular pathogenesis of the chromosome 16 inversion in the M4Eo subtype of acute myeloid leukemia Blood 85 1995 2289
183. Look A.T. Oncogenic transcription factors in the human acute leukemias Science 278 1997 1059
184. Lowsky R. DeCoteau J.F. Reitmair A.H. Defects of the mismatch repair gene MSH2 are implicated in the development of murine and human lymphoblastic lymphomas and are associated with the aberrant expression of rhombotin-2 (Lmo-2) and Tal-1 (SCL) Blood 89 1997 2276
185. Lutterbach B. Westendorf J.J. Linggi B. ETO, a target of t(8;21) in acute leukemia, interacts with N-cor and mSin3 corepressors Mol Cell Biol 18 1998 7176
186. Magrath I. Adde M. Shad A. Adults and children with small non-cleaved-cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen J Clin Oncol 14 1996 925
187. Mandelli F. Diverio D. Avvisati G. Molecular remission in PML/RARa-positive acute promyelocytic leukemia by combined all -trans retinoic acid and idarubicin therapy Blood 90 1997 1014
188. Mangelsdorf D.J. Evans R.M. The RXR heterodimers and orphan receptors Cell 83 1995 841
189. Marcucci G. Caligiuri M.A. Bloomfield C.D. Defining the “ absence” of the CRFβ/ MYH11 fusion transcript in patients with acute myeloid leukemia and inversion of chromosome 16 to predict long-term complete remission: A call for definitions [letter] Blood 90 1997 5022
190. Marcucci G. Livak K.J. Bi W. Detection of minimal residual disease in patients with AMLl/ETO-associated acute myeloid leukemia using a novel quantitative reverse transcription polymerase chain reaction assay Leukemia 12 1998 1482
191. Martinez-Climent J.A. Garcia-Conde J. Chromosomal rearrangements in childhood acute myeloid leukemia and myelodysplastic syndromes J Pediatr Hematol Oncol 21 1999 91
192. Martinez-Climent J.A. Thirman M.J. Espinosa R. III Detection of 11q23/MLL rearrangements in infant leukemia with fluorescence in-situ hybridization and molecular analysis Leukemia 9 1995 1299
193. Maruyama F. Peirong S. Stass S. Detection of the AML1/ETO fusion transcript in the t(8;21) translocation in acute myeloid leukemia Cancer Res 53 1993 4449
194. McClure J.S. Litz C.E. Chronic myelogenous leukemia: Molecular diagnostic considerations Hum Pathol 25 1994 594
195. McGuire E.A. Rintoul C.E. Sclar G.M. Korsmeyer S.J. Thymic overexpression of Ttg-1 in transgenic mice results in T-cell acute lymphoblastic leukemia/lymphoma Mol Cell Biol 12 1992 4186
196. McLean T.W. Ringold S. Neuberg D. TEL/AML1 dimerizes and is associated with a favorable outcome in childhood acute lymphoblastic leukemia Blood 88 1996 4252
197. Mellentin J.D. Murre C. Donlon T.A. The gene for enhancer binding proteins E12/E47 lies at the t(1;19) breakpoint in acute leukemias Science 246 1989 379
198. Melo J.V. The diversity of BCR-ABL fusion proteins and their relationship to leukemia phenotype Blood 88 1996 2375
199. Mensink E. van de Locht A. Schattenberg A. Quantitation of minimal residual disease in Philadelphia chromosome positive chronic myeloid leukaemia patients using real-time quantitative RT-PCR Br J Haematol 102 1998 768
200. Merlo A. Herman J.G. Mao L. 5’ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTSl in human cancers Nat Med 1 1995 686
201. Meyers S. Downing J.R. Hiebert S.W. Identification of AML-1 and the (8;21) translocation protein (AML-1/ETO) as sequence-specific DNA-binding proteins: The runt homology domain is required for DNA binding and protein-protein interactions Mol Cell Biol 13 1993 6336
202. Meyers S. Lenny N. Sun W. Hiebert S.W. AML-2 is a potential target for transcriptional regulation by the t(8;21) and t(12;21) fusion proteins in acute leukemia Oncogene 13 1996 303
203. Michael P.M. Levin M.D. Garson O.M. Translocation l;19-a new cytogenetic abnormality in acute lymphoblastic leukemia Cancer Genet Cytogenet 12 1984 333
204. Miller W.H. Kakizuka A. Frankel S.R. Reverse transcription polymerase chain reaction for the rearranged retinoic acid receptor a clarifies diagnosis and detects minimal residual disease in acute promyelocytic leukemia Proc Natl Acad Sci U S A 89 1992 2694
205. Miller W.H. Jr Levine K. DeBlasio A. Detection of minimal residual disease in acute promyelocytic leukemia by a reverse transcription polymerase chain reaction assay for the PML/RAR-a fusion mRNA Blood 82 1993 1689
206. Minucci S. Ozato K. Retinoid receptors in transcriptional regulation Curr Opin Genet Dev 6 1996 567
207. Mirro J. Kitchingman G. Williams D. Clinical and laboratory characteristics of acute leukemia with the 4;11 translocation Blood 67 1986 689
208. Mitani K. Kanda Y. Ogawa S. Cloning of several species of MLL/MEN chimeric cDNAs in myeloid leukemia with t(11;19)(q23;p13.1) translocation Blood 85 1995 2017
209. Miyamoto K. Tomita N. Ishii A. Chromosome abnormalities of leukemic cells in adult patients with T-cell leukemia J Natl Cancer Inst 73 1984 353
210. Miyamoto T. Nagafuji K. Akashi K. Persistence of multipotent progenitors expressing AML1/ETO transcripts in long-term remission patients with t(8;21) acute myelogenous leukemia Blood 87 1996 4789
211. Miyamura K. Tanimoto M. Morishima Y. Detection of Philadelphia chromosomepositive acute lymphoblastic leukemia by polymerase chain reaction, possible eradication of minimal residual disease by marrow transplantation Blood 79 1992 1366
212. Miyoshi H. Kozu T. Shimizu K. The t(8;21) translocation in acute myeloid leukemia results in production of an AML1-MTG8 transcript EMBO J 12 1993 2715
213. Miyoshi H. Shimizu K. Kozu T. The t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia clustered within a limited region of a novel gene AML1 Proc Natl Acad Sci U S A 88 1991 10431
214. Monica K. LeBrun D.P. Dedera D.A. Transformation properties of the E2a-Pbxl chimeric oncoprotein: Fusion with E2a is essential, but the Pbxl homeodomain is dispensable Mol Cell Biol 14 1994 8304
215. Morrissey J. Tkachuk D.C. Milatovich A. A serine/proline-rich protein is fused to HRX in t(4;11) acute leukemias Blood 81 1993 1124
216. Murre C. Voronova A. Baltimore D. B-cell and monocyte-specific E2-box-binding factors contain E12/E47-like subunits Mol Cell Biol 11 1991 1156
217. Nakao M. Yokota S. Horiike S. Detection and quantification of TEL/AML1 fusion transcripts by polymerase chain reaction in childhood acute lymphoblastic leukemia Leukemia 10 1996 1463
218. Negrini M. Felix C.A. Martin C. Potential topoisomerase II DNA-binding sites at the breakpoints of a t(9;11) chromosome translocation in acute myeloid leukemia Cancer Res 53 1993 4489
219. Neves H. Ramos C. Gomes da Silva M. The nuclear topography of ABE, BCR , PML and RARα genes: Evidence for gene proximity in specific phases of the cell cycle and stages of hematopoietic differentiation Blood 93 1999 1197
220. Nisson P.E. Watkins P.C. Sacchi N. Transcriptionally active chimeric gene derived from the fusion of the AML1 gene and a novel gene on chromosome 8 in the t(8;21) leukemic cells Cancer Genet Cytogenet 63 1992 81
221. Nizet Y. Martiat P. Vaerman J.L. Follow-up of residual disease (MRD) in B lineage acute leukaemias using a simplied PCR strategy: Evolution of MRD rather than its detection is correlated with clinical outcome Br J Haematol 79 1991 205
222. Nizet Y. Van Daele S. Lewalle P. Long-term follow-up of residual disease in acute lymphoblastic leukemia patients in complete remission using clonogeneic IgH probes and the polymerase chain reaction Blood 82 1993 1618
223. Nolte M. Werner M. Ewig M. Fluorescence in situ hybridization (FISH) is a reliable diagnostic tool for detection of the 9;22 translocation Leuk Lymphoma 22 1996 287
224. Nourse J. Mellentin J.D. Galili N. Chromosomal translocation t(1;19) results in synthesis of a homeobox fusion mRNA that codes for a potential chimeric transcription factor Cell 60 1990 535
225. Nuchprayoon I. Meyers S. Scott L.M. PEBP2/CBF, the murine homolog of the human myeloid AML1 and PEBP2beta/CBFbeta proto-oncoproteins, regulates the murine myeloperoxidase and neutrophil elastase genes in immature myeloid cells Mol Cell Biol 14 1994 5558
226. Nucifora G. Larson R.A. Rowley J.D. Persistence of 8;21 translocation in patients with acute myeloid leukemia type M2 in long-term remission Blood 82 1993 712
227. Nucifora G. Rowley J.D. AML1 and the 8;21 and 3;21 translocations in acute and chronic myeloid leukemia Blood 86 1995 1
228. Numata S-I. Kato K. Horibe K. New E2A/PBX1 fusion transcript in a patient with t(1;19)(q23;p13) acute lymphoblastic leukemia Leukemia 7 1993 1441
229. Ogawa E. Inuzuka M. Maruyama M. Molecular cloning and characterization of PEBP2β, the heterodimeric partner of a novel Drosophila runt- related DNA binding protein PEBP2a Virology 194 1993 314
230. Ogawa E. Maruyama M. Kagoshima H. PEBP2/PEA represents a new family of transcription factor homologous to the products of the Drosophila runt and the human AML1 Proc Natl Acad Sci USA 90 1993 6859
231. Ogawa S. Hangaishi A. Miyawaki S. Loss of the cyclin-dependent kinase 4-inhibitor (p16;MTS1) gene is frequent and highly specific to lymphoid tumors in primary human hematopoietic malignancies Blood 86 1995 1548
232. Ohnishi H. Kawamura M. Ida K. Homozygous deletions of p16 /MTS1 gene are frequent but mutations are infrequent in childhood T-cell acute lymphoblastic leukemia Blood 86 1995 1269
233. Ohno H. Inoue T. Akasaka T. Acute lymphoblastic leukemia associated with a t(1;19)(q23;p13) in an adult Intern Med 32 1993 584
234. Okuda T. Cai Z. Yang S. Expression of a knocked-in AML1-ETO leukemia gene inhibits the establishment of normal definitive hematopoiesis and directly generates dysplastic hematopoietic progenitors Blood 91 1998 3134
235. Okuda T. Shurtleff S.A. Valentine M.B. Frequent deletion of p16INK4a/MTSl and p15INK4b/MTS2 in pediatric acute lymphoblastic leukemia Blood 85 1995 2321
236. Okuda T. van Deursen J. Hiebert S.W. AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoeisis Cell 84 1996 321
237. Pandolfi P.P. Alcalay M. Fagioli M. Genomic variability and alternative splicing generate multiple PML/RARa transcripts that encode aberrant PML proteins and PML/RARa isoforms in acute promyelocytic leukemia EMBO J 11 1992 1397
238. Papadopoulos P. Ridge S.A. Boucher C.A. The novel activation of ABL by fusion to an efs-related gene, TEL Cancer Res 55 1995 34
239. Parkin J.L. Arthur D.C. Abramson C.S. Acute leukemia associated with the t(4;11) chromosome rearrangement: Ultrastructural and immunologic characteristics Blood 60 1982 1321
240. Patte C. Philip T. Rodary C. High survival rate in advanced-stage-B-cell lymphomas and leukemias without CNS involvement with a short intensive poly chemotherapy: Results from the French Pediatric Oncology Society of a randomized trial of 216 children J Clin Oncol 9 1991 123
241. Pearson L. Leith C.P. Duncan M.H. Multidrug resistance-1 (MDR1) expression and functional dye/drug efflux is highly correlated with the t(8;21) chromosomal translocation in pediatric acute myeloid leukemia Leukemia 10 1996 1274
242. Poirel H. Radford-Weiss I. Rack K. Detection of the chromosome 16 CBFβ-MYH11 fusion transcript in myelomonocytic leukemia Blood 85 1995 1313
243. Ponger-Willemse M.J. Seriu T. Stolz F. Primers and protocols for standardized detection of minimal residual disease in acute lymphoblastic leukemia using immunoglobulin and T cell receptor gene rearrangements and TALI deletions as PCR targets. Report of the Biomed-1 Concerted Action: Investigation of minimal residual disease in acute leukemia Leukemia 13 1999 110
244. Pongers-Willemse M.J. Verhagen OJHM. Tibbe G.J.M. Real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia using junctional region specific TaqMan probes Leukemia 12 1998 2006
245. 1)-positive acute lymphoblastic leukemia (ALL) Leukemia 11 1997 294
246. Privitera E. Kamps M.P. Hayashi Y. Different molecular consequences of the 1;19 chromosomal translocation in childhood B-cell precursor acute lymphoblastic leukemia Blood 79 1992 1781
247. Pui C-H. Childhood leukemias N Engl J Med 332 1995 1618
248. Pui C.H. Behm F.G. Downing J.R. 11q23/MLL rearrangement confers a poor prognosis in infants with acute lymphoblastic leukemia J Clin Oncol 12 1994 909
249. Pui C.H. Behm F.G. Raimondi S.C. Secondary acute myeloid leukemia in children treated for acute lymphoid leukemia N Engl J Med 321 1989 136
250. Pui C-H. Behm F.G. Singh B. Heterogeneity of presenting features and their relationship to treatment outcome in 120 children with T-cell acute lymphoblastic leukemia Blood 75 1990 174
251. Pui C-H. Frankel L.S. Carroll A.J. Clinical characteristics and treatment outcome of childhood acute lymphoblastic leukemia with the t(4;11)(q21;q23): A collaborative study of 40 cases Blood 77 1991 440
252. Pui C-H. Kane J.R. Crist W.M. Biology and treatment of infant leukemias Leukemia 9 1995 762
253. Pui C-H. Raimondi S.C. Hancock M.L. Immunologic, cytogenetic, and clinical characterization of childhood acute lymphoblastic leukemia with the t(1;19)(q23;p13) or its derivative J Clin Oncol 12 1994 2601
254. Pui C-H. Ribeiro R.C. Hancock M.L. Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia N Engl J Med 325 1991 1682
255. Pulford K. Lecointe N. Leroy Viard K. Expression of TAL-1 proteins in human tissues Blood 85 1995 675
256. Pullen D.J. Sullivan M.P. Falletta J.M. Modified LSA2-L2 treatment in 53 children with E-rosette-positive T-cell leukemia: Results and prognostic factors (a Pediatric Oncology Group study) Blood 60 1982 1159
257. Quelle D.E. Zindy F. Ashmun R.A. Sherr C.J. Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest Cell 83 1995 993
258. Quignon F. De Bels F. Koken M. PML induces a novel caspase-independent death process Nat Genet 20 1998 259
259. Rabbitts T.H. Translocations, master genes and differences between the origins of acute and chronic leukemias Cell 67 1991 641
260. Radich J. Gehly G. Lee A. Detection of bcr-abl transcripts in Philadelphia chromosome-positive acute lymphoblastic leukemia after marrow transplantation Blood 89 1997 2602
261. Raimondi S.C. Current status of cytogenetic research in childhood acute lymphoblastic leukemia Blood 81 1993 2237
262. Raimondi S.C. Behm F.G. Roberson P.K. Cytogenetics of pre-B-cell acute lymphoblastic leukemia with emphasis on prognostic implications of the t(1;19) J Clin Oncol 8 1990 1380
263. Raimondi S.C. Frestedt J.L. Pui C-H. Acute lymphoblastic leukemias with deletion of 1q23 or a novel inversion (11)(p13q23) lack MLL gene rearrangements and have favorable clinical features Blood 86 1995 1881
264. Rasool O. Heyman M. Brandter L.B. p15ink4b and p16ink4 gene inactivation in acute lymphocytic leukemia Blood 85 1995 3431
265. Rauskolb C. Peifer M. Weischaus E. Extradenticle , a regulator of homeotic gene activity, is a homolog of the homeobox-containing human proto-oncogene pbxl Cell 74 1993 1101
266. Raynaud S. Cavé H. Baens M. The 12;21 translocation involving TEL and deletion of the other TEL allele: Two frequently associated alterations found in childhood acute lymphoblastic leukemia Blood 87 1996 2891
267. Redner R.L. Rush E.A. Faas S. The t(5;17) variant of acute promyelocytic leukemia expresses a nucleophosmin-retinoic acid receptor fusion Blood 87 1996 882
268. Redondo J.M. Hata S. Brocklehurst C. Krangel M.S. A T-cell-specific transcriptional enhancer within the human T-cell receptor δ locus Science 247 1990 1225
269. Repp R. Borkhardt A. Haupt E. Detection of four different 11q23 chromosomal abnormalities by multiplex-PCR and fluorescence-based automatic DNA-fragment analysis Leukemia 9 1995 210
270. Rhoades K. Hetherington C.J. Rowley J.D. Synergistic up-regulation of the myeloid-specific promoter for the macrophage colony-stimulating factor receptor by AML1 and the t(8;21) fusion protein may contribute leukemogenesis Proc Natl Acad Sci U S A 93 1996 11895
271. Rivera G.K. Raimondi S.C. Hancock M.L. Improved outcome in childhood acute lymphoblastic leukemia with reinforced early treatment and rotational combination chemotherapy Lancet 337 1991 61
272. Roberts C.W. Shutter J.R. Korsmeyer S.J. Hoxll controls the genesis of the spleen Nature 368 1994 747
273. Roberts W.M. Estrov Z. Ouspenskaia M.V. Measurement of residual leukemia during remission in childhood acute lymphoblastic leukemia N Engl J Med 336 1997 317
274. Roberts W.M. Rivera G.K. Raimondi S.C. Intensive chemotherapy for Philadelphia-chromosome-positive acute lymphoblastic leukemia Lancet 343 1994 331
275. Romana S.P. Mauchaffe M. Le Coniat M. The t(12;21) of acute lymphoblastic leukemia results in a tel-AMLl gene fusion Blood 85 1995 3662
276. Romana S.P. Poirel H. Leconiat M. High frequency of t(12;21) in childhood B-lineage acute lymphoblastic leukemia Blood 86 1995 4263
277. Rovelli A. Biondi A. Cantu Rajnoldi A. Microgranular variant of acute promyelocytic leukemia in children J Clin Oncol 10 1992 1413
278. Rowley J.D. Backtracking leukemia to birth Nat Med 4 1998 150
279. Rubnitz J.E. Behm F.G. Downing J.R. 11q23 rearrangements in acute leukemia Leukemia 10 1996 74
280. Rubnitz J.E. Behm F.G. Pui C-H. Genetic studies of childhood acute lymphoblastic leukemia with emphasis on p16, MEL, and ETV6 gene abnormalities: Results of St. Jude Total therapy Study XII Leukemia 11 1997 1201
281. Rubnitz J.E. Behm F.G. Wichlan D. Low frequency of TEL-AML1 in relapsed acute lymphoblastic leukemia supports a favorable prognosis for this genetic subgroup Leukemia 13 1998 19
282. Rubnitz J.E. Downing J.R. Pui C-H. TEL gene rearrangement in acute lymphoblastic leukemia: A new genetic marker with prognostic significance J Clin Oncol 15 1997 1150
283. Rubnitz J.E. Link M.P. Shuster J.J. Frequency and prognostic significance of HRX rearrangements in infant acute lymphoblastic leukemia: A Pediatric Oncology Group study Blood 84 1994 570
284. Rubnitz J.E. Look A.T. Molecular genetics of childhood leukemias J Pediatr Hematol Oncol 20 1998 1
285. Rubnitz J.E. Pui C-H. Downing J.R. The role of TEL fusion genes in pediatric leukemias Leukemia 13 1999 6
286. Rubnitz J.E. Shuster J.J. Land V.J. Case-control study suggests a favorable impact of TEL rearrangement in patients with B-lineage acute lymphoblastic leukemia treated with antimetabolite-based therapy: A pediatric oncology group study Blood 89 1997 1143
287. Salvati P.D. Ranford P.R. Ford J. HOX11 expression in pediatric acute lymphoblastic leukemia is associated with T-cell phenotype Oncogene 11 1995 1333
288. Satake N. Kobayashi H. Tsunematsu Y. Minimal residual disease with TEL-AML1 fusion transcript in childhood lymphoblastic leukemia with t(12;21) Br J Haematol 97 1997 607
289. Satake N. Maseki M. Nishiyama M. Chromosome abnormalities and MLL rearrangements in acute myeloid leukemia of infants Leukemia 13 1999 1013
290. Schaefer-Rego K. Arlin Z. Ahpiro L.G. Molecular heterogeneity of adult Ph chromosome-positive acute lymphoblastic leukemia Cancer Res 48 1988 866
291. Schena M. Shalon D. Heller R. Parallel human genome analysis: Microarray-based expression monitoring of 1000 genes Proc Natl Acad Sci U S A 93 1996 10614
292. Schichman S.A. Caligiuri M.A. Gu Y. ALL-1 partial duplication in acute leukemia Proc Natl Acad Sci U S A 91 1994 6236
293. Schichman S.A. Caligiuri M.A. Strout M.P. ALL-1 tandem duplication in acute myeloid leukemia with a normal karyotype involves homologous recombination between Alu elements Cancer Res 54 1994 4277
294. Schoch C. Haase D. Haferlach T. Fifty-one patients with acute myeloid leukemia and translocation t(8;21)(q22;q22): An additional deletion in 9q is an adverse prognostic factor Leukemia 10 1996 1288
295. Scurto P. Hsu Rocha M. Kane J.R. A multiplex RT-PCR assay for the detection of chimeric transcripts encoded by the risk-stratifying translocations of pediatric acute lymphoblastic leukemia Leukemia 12 1998 1994
296. Seeker-Walker L.M. Berger R. Fenaux P. Prognostic significance of the balanced t(1;19) and unbalanced der(19)t(1;19) translocations in acute lymphoblastic leukemia Leukemia 6 1992 363
297. Seeker-Walker L.M. Craig J.M. Hawkins J.M. Hoffbrand A.V. Philadelphia positive acute lymphoblastic leukemia in adults: Age distribution, BCR breakpoint and prognostic significance Leukemia 5 1991 196
298. Seeger K. Adams H.P. Buchwald D. TEL-AML1 fusion transcript in relapsed childhood acute lymphoblastic leukemia Blood 91 1998 1716
299. Seriu T. Yokota S. Nakao M. Prospective monitoring of minimal residual disease during the course of chemotherapy in patients with acute lymphoblastic leukemia, and detection of contaminating tumor cells in peripheral blood stem cells for autotransplantation Leukemia 9 1995 615
300. Shalon D. Smith S.J. Brown P.O. A DNA microarray system for analyzing complex DNA samples using two-color fluorescent probe hybridization Genome Res 6 1996 639
301. Shurtleff S.A. Buijs A. Behm F.G. TEL/AML1 fusion resulting from a cryptic t(12;21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with a excellent prognosis Leukemia 9 1995 1985
302. Shurtleff S.A. Meyers S. Hiebert S.W. Heterogeneity in CBFb/MYHll fusion messages encoded by the inv(16)(p13;q22) and the t(16;16)(p13;q22) in acute myelogenous leukemia Blood 85 1995 3695
303. Simon M. Kind P. Kaudewitz P. Automated high-resolution polymerase chain reaction fragment analysis. A method for detecting T-cell receptor γ-chain gene rearrangements in lymphoproliferative diseases Am J Pathol 152 1998 29
304. Slack J.L. Willman C.L. Li Y-P. Molecular characterization and clinical features of adult APL patients with the type “V” PML-RARα isoform: Results from Intergroup protocol 0129 Blood 88 1996 664A
305. Smith F.O. Rauch C. Williams D.E. The human homologue of rat NG2, a chondroitin sulfate proteoglycan, is not expressed on the cell surface of normal hematopoietic cells but is expressed by acute myeloid leukemia blasts from poor-prognosis patients with abnormalities of chromosome band 11q23 Blood 87 1996 1123
306. Smith M.A. Rubinstein L. Ungerleider R.S. Therapy-related acute myeloid leukemia following treatment with epipodophyllotoxins: estimating the risks Med Pediatr Oncol 23 1994 86
307. Speck N.A. Stacy T. A new transcription factor family associated with human leukemias Crit Rev Eukaryot Gene Expr 5 1995 337
308. Speck N.S. Stacy T. Wang Q. Core-binding factor: A central player in hematopoiesis and leukemia Cancer Res 59 1999 1789s
309. Steenbergen E.J. Verhagen OJHM. van Leeuwen E.F. Prolonged persistence of PCR-detectable minimal residual disease after diagnosis or first relapse predicts poor outcome in childhood B-precursor acute lymphoblastic leukemia Leukemia 9 1995 1726
310. Stissel Broeker P.L. Super H.G. Thirman M.J. Distribution of 11q23 breakpoints within the MLL breakpoints cluster region in de novo acute leukemia and in treatment-related acute myeloid leukemia: Correlation with scaffold attachment regions and topoisomerase II consensus binding sites Blood 87 1996 1912
311. Stranks G. Height S.E. Mitchell P. Deletions and rearrangement of CDKN2 in lymphoid malignancy Blood 85 1995 893
312. Strong R.C. Korsmeyer S.J. Parkin J.L. Human acute leukemia cell line with the t(4;11) chromosomal rearrangement exhibits B-lineage and monoclonal characteristics Blood 65 1985 21
313. Super H.J. McCabe N.R. Thirman M.J. Rearrangements of the MLL gene in therapy-related acute myeloid leukemia in patients previously treated with agents targeting DNA-topoisomerase II Blood 82 1993 3705
314. Taki T. Ida K. Bessho F. Frequency and clinical significance of the MLL gene rearrangements in infant acute leukemia Leukemia 10 1996 1303
315. Tallman M.S. Andersen J.W. Schiffer C.A. All-fnms-retinoic acid in acute promyelocytic leukemia N Engl J Med 337 1997 1021
316. Tbakhi A. Pettay J. Sreenan J.J. Comparative analysis of interphase FISH and RT-PCR to detect bcr-abl translocation in chronic myelogenous leukemia and related disorders Am J Clin Pathol 109 1998 16
317. Tkachuk D.C. Kohler S. Cleary M.L. Involvement of a homolog of Drosophila trithorax by 11q23 chromosomal translocations in acute leukemias Cell 71 1992 691
318. Tobal K. Johnson P.R. Saunders M.J. Detection of CBFB/MYH11 transcripts in patients with inversion and other abnormalities of chromosome 16 at presentation and remission Br J Haematol 91 1995 104
319. Tobal K. Liu Yin J.A. Monitoring of minimal residual disease by quantitative reverse transcriptase-polymerase chain reaction for AML1-MTG8 transcripts in AML-M2 with t(8;21) Blood 88 1996 3704
320. Trka J. Zuna J. Hrusak O. No evidence for MLL/AF4 expression in normal cord blood samples Blood 93 1999 1106
321. Tycko B. Smith S.D. Sklar J. Chromosomal translocations joining lek and tcrb loci in human T cell leukemia J Exp Med 174 1991 867
322. Uckun F.M. Herman-Hatten K. Crotty M-L. Clinical significance of MLL-AF4 fusion transcript expression in the absence of a cytogenetically detectable t(4;11)(q21;q23) chromosomal translocation Blood 92 1998 810
323. Uckun F.M. Sensei M.G. Sun L. Biology and treatment of childhood T-lineage acute lymphoblastic leukemia Blood 91 1998 735
324. Vagner-Capodano A.M. Mozziconacci M.J. Zattar-Cannoni H. t(1;19) in a M4-ANLL Cancer Genet Cytogenet 73 1994 86
325. Van der Reijden B.A. Lombardo M. Dauwerse J.G. RT-PCR diagnosis of patients with acute non-lymphocytic leukemia and inv(16)(p13q22) and identification of new alternative splicing in CBFB-MYH11 transcripts Blood 86 1995 277
326. Van der Reijden B.A. Martinet D. Dauwerse J.G. Simple method for detection of MYH11 DNA rearrangements in patients with inv(16)(p13q22) and acute myeloid leukemia Leukemia 10 1996 1459
327. van Dongen J.J.M. Seriu T. Panzer-Grümayer E.R. Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood Lancet 352 1998 1731
328. Viswanatha D.S. Chen I-M. Liu P.P. Characterization and use of an antibody detecting the CBFβ-SMMHC fusion protein in inv(16)/t(16;16)-associated acute myeloid leukemias Blood 91 1998 1882
329. Voncken J.W. Kaartinen V. Pattengale P.K. BCR/ABL P210 and P190 cause distinct leukemia in transgenic mice Blood 86 1995 4603
330. Wang Q. Stacy T. Binder M. Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis Proc Natl Acad Sci U S A 93 1996 3444
331. Wang Q. Stacy T. Miller J.D. The CBFβ subunit is essential for CBFa2 (AML1) function in vivo Cell 87 1996 697
332. Wang S. Wang Q. Crute B.E. Cloning and characterization of subunits of the T-cell receptor and murine leukemia virus enhancer core-binding factor Mol Cell Biol 13 1993 3324
333. Wang Z-G. Ruggero D. Ronchetti S. Pml is essential for multiple apoptotic pathways Nat Genet 20 1998 266
334. Waring P.M. Cleary M.L. Disruption of a homolog of trithorax by 11q23 translocations: Leukemogenic and transcriptional implications Curr Top Microbiol Immunol 220 1997 1
335. Wasserman R. Galili N. Ito Y. Residual disease at the end of induction therapy as a predictor of relapse during therapy in childhood B-lineage acute lymphoblastic leukemia J Clin Oncol 10 1992 1879
336. Weis K. Rambaud S. Lavau C. Retinoic acid regulates aberrant nuclear localization of PML-RARα in acute promyelocytic leukemia Cell 76 1994 345
337. Wittwer C.T. Hermann M.G. Moss A.A. Continuous fluorescence monitoring of rapid cycle DNA amplification Biotechniques 22 1997 130
338. Wlodarska I. Mecucci C. Marynen P. TEL gene is involved in myelodysplastic syndromes with either the typical t(5;12)(q33;p13) translocation or its variant t(10;12)(q24;p13) Blood 85 1995 2848
339. Wlodarska I. Stul M. DeWolf-Peeters C. t(1;19) without detectable E2A rearrangements in two t(14;18)-positive lymphoma/leukemia cases Genes Chromosomes Cancer 10 1994 171
340. Wu N.H. Lu S.G. Zhu P. Peng Y.Y. Detection of minimal residual disease in childhood acute lymphoblastic leukemia after termination of therapy Pediatr Hematol Oncol 13 1996 257
341. Yamada T. Craig J.M. Hawkins J.M. Molecular investigation of 19p13 in standard and variant translocations: The E12 probe recognizes the 19p13 breakpoint in cases with t(1;19) and acute leukemia other than pre-B immunophenotype Leukemia 5 1991 36
342. Yamamoto K. Seto M. Iida S. A reverse transcripase-polymerase chain reaction detects heterogeneous chimeric mRNAs in leukemias with 11q23 abnormalities Blood 83 1994 2912
343. Yergeau D.A. Hetherington C.J. Wang Q. Embryonic lethality and impairment of haematopoiesis in mice heterozygous for an AML1-ETO fusion gene Nat Genet 15 1997 303
344. Young B.D. Saha V. Chromosome abnormalities in leukaemia: The 11q23 paradigm Cancer Surv 28 1996 225
345. Yu B.D. Hess J.L. Horning S.E. Altered Hox empression and segmental identity in Mil-mutant mice Nature 378 1995 505
346. Zeleznik-Le N.J. Harden A.M. Rowley J.D. 11q23 translocations split the “AT-hook” cruciform DNA-binding region and the transcriptional repression domain from the activation domain of the mixed-lineage leukemia (MLL) gene Proc Natl Acad Sci U S A 91 1994 10610
347. Zervos A.S. Gyuris J. Brent R. Mxil, a protein that specifically interacts with Max to bind Myc-Max recognition sites Cell 72 1993 223
348. Zhang D-R. Fujioka K-I. Hetherington C.J. Identification of a region which directs monocytic activity of the CSF-1 (M-CSF) receptor promoter and binds PEBP2/CBF (AML1) Mol Cell Biol 16 1996 1231
349. Zhang T. Hillion J. Tong J-H. AML-1 gene rearrangement and AML1-ETO gene expression as molecular markers for acute myeloblastic leukemia with t(8;21) Leukemia 8 1994 729
350. Zheng P. Guo Y. Niu Q. Proto-oncogene PML controls genes devoted to MHC class I antigen presentation Nature 396 1998 373
351. Zhuang Y. Soriano P. Weintraub H. The helix-loop-helix gene E2A is required for B-cell formation Cell 79 1994 875
352. Zutter M. Hockett R.D. Roberts C.W. The t(10;14)(q24;q11) of T-cell acute lymphoblastic leukemia juxtaposes the delta T-cell receptor with TCL3, a conserved and activated locus at 10q24 Proc Natl Acad Sci U S A 87 1990 3161